window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : March 26, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us
Veeva Systems Leaderboard Advert
DP Magazine HomeDebbie2025-10-10T16:39:02+01:00
Top News
Mar 25: Quotient and Merck partner on somatic genomics drug targets in inflammatory bowel disease
Mar 25: Primerdesign and Origin partner on rectal mucus DNA extraction for colorectal cancer detection
Mar 23: insitro and Bristol Myers Squibb expand ALS targets in AI collaboration
Mar 23: Laigo Bio raises €17m seed funding to advance oncology pipeline
Mar 23: Abselion hires Dale Gordon as chair to support growth push
  • Biotech,CDMOs & Manufacturing,Clinical Trials,Funding,Healthcare leadership,Oncology

    Mestag Therapeutics raises $40M and adds leadership ahead of cancer trial

    By Liza Laws|Last Updated: 23 March 2026|
  • Drug discovery,Gastroenterology,Immunology,Partnerships & Funding,Research & Development

    Quotient and Merck partner on somatic genomics drug targets in inflammatory bowel disease

  • Diagnostics,Gastroenterology,Genomics and sequencing,Partnerships & Funding,Technology and platforms

    Primerdesign and Origin partner on rectal mucus DNA extraction for colorectal cancer detection

top headlines

  • Artificial Intelligence,Drug discovery,Neurosciences,Partnerships & Funding

    insitro and Bristol Myers Squibb expand ALS targets in AI collaboration

    insitro and Bristol Myers Squibb have expanded their ALS collaboration [...]

    March 23, 2026
  • Biotech,Funding,Immunology,Oncology,Research & Development

    Laigo Bio raises €17m seed funding to advance oncology pipeline

    Laigo Bio has completed a €17 million seed financing round [...]

    March 23, 2026
related posts
  • Abselion hires Dale Gordon as chair to support growth push
    By Liza Laws|Categories: Healthcare leadership, Movers & Shakers|
  • Liver disease linked to higher heart failure risk in AFib patients
    By Liza Laws|Categories: Cardiovascular diseases, Clinical studies, Metabolic Diseases|
  • Codexis signs siRNA manufacturing deal for cardiovascular programme
    By Liza Laws|Categories: CDMOs & Manufacturing, Drug Development, Manufacturing, RNA Therapeutics|
related posts
  • Evotec unit secures BARDA deal to optimise Ebola antibody manufacturing
    By Liza Laws|Categories: Biomanufacturing, CDMOs & Manufacturing, Infectious Diseases, Partnerships & Funding, Vaccines|
  • Mestag Therapeutics raises $40M and adds leadership ahead of cancer trial
    By Liza Laws|Categories: Biotech, CDMOs & Manufacturing, Clinical Trials, Funding, Healthcare leadership, Oncology|
  • PolyPid prepares D-PLEX100 NDA following Phase 3 surgical infection data
    By Liza Laws|Categories: Clinical Development, Clinical Trials, Drug Development, FDA, Infectious Diseases|

Movers & Shakers

  • Abselion hires Dale Gordon as chair to support growth push
    Categories: Healthcare leadership, Movers & Shakers
  • Link Biologics appoints Niall Martin to board as TSG-6 pipeline advances towards clinic
    Categories: Biologics & Biosimilars, Biotech, Drug discovery, European biotech, Healthcare leadership, Movers & Shakers, Opthalmology, Research & Development
  • Aspargo Labs appoints Sam Backenroth as chief financial officer to strengthen corporate and capital markets leadership
    Categories: Biotech, Healthcare leadership, Movers & Shakers, Partnerships & Funding, Pharmaceuticals and therapeutics
  • Oryzon appoints Rolando Gutierrez-Esteinou as chief medical officer for CNS programs
    Categories: Central Nervous System, Clinical Development, Movers & Shakers, Neurosciences, Pharmaceuticals and therapeutics
  • Nucleome Therapeutics appoints Michelle Morrow as chief scientific officer
    Categories: European biotech, Immunology, Movers & Shakers, Research & Development

sponsored content

Cardiovascular diseases,Clinical Trials,Rare Diseases

Rare Disease Day 2026: Cereno Scientific advances disease-modifying therapies in PAH

As Rare Disease Day 2026 shines a spotlight on patients [...]

continue readingcontinue reading
Rare Diseases

Rare Disease Day 2026: Er-Kim pushes to close access gap in underserved markets

As Rare Disease Day 2026 highlights the challenges faced by [...]

continue readingcontinue reading
Artificial Intelligence,Data Management,Market Access & Commercialization,Pharmaceuticals and therapeutics,Technology and platforms

5 Insights on Data Foundations From Top Pharma Leaders

As the pharmaceutical industry moves from AI experimentation to execution, [...]

continue readingcontinue reading
Cell & Gene Therapy,Clinical Development,Oncology,Partnerships & Funding,Research & Development

Affibody advances radioligand therapies for precision oncology

On World Cancer Day (WCD), Affibody highlights its progress in [...]

continue readingcontinue reading

Other news

  • Cardiovascular diseases,Clinical studies,Metabolic Diseases

    Liver disease linked to higher heart failure risk in AFib patients

    Liver-metabolic disease is linked to increased heart failure risk in [...]

    read more
  • CDMOs & Manufacturing,Drug Development,Manufacturing,RNA Therapeutics

    Codexis signs siRNA manufacturing deal for cardiovascular programme

    Codexis has signed an agreement to manufacture siRNA for a [...]

    read more
  • Biomanufacturing,CDMOs & Manufacturing,Infectious Diseases,Partnerships & Funding,Vaccines

    Evotec unit secures BARDA deal to optimise Ebola antibody manufacturing

    Just – Evotec Biologics has been selected by BARDA to [...]

    read more
  • Clinical Development,Clinical Trials,Drug Development,FDA,Infectious Diseases

    PolyPid prepares D-PLEX100 NDA following Phase 3 surgical infection data

    PolyPid is preparing to submit a New Drug Application for [...]

    read more
  • CDMOs & Manufacturing,Cell & Gene Therapy,Manufacturing,Technology and platforms

    Sartorius launches Eveo platform targeting cell therapy manufacturing bottlenecks

    Sartorius has launched a new platform designed to address manufacturing [...]

    read more
  • Clinical Development,Clinical Trials,Oncology,Partnerships & Funding,Technology and platforms

    One-carbon partners Tempus to support TH9619 development in solid tumours

    One-carbon Therapeutics has signed a collaboration with Tempus to generate [...]

    read more
Mail Icon

news via inbox

Sign up for our newsletter and get the latest news right in your inbox

SUBSCRIBE

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • One-carbon partners Tempus to support TH9619 development in solid tumours
    Categories: Clinical Development, Clinical Trials, Oncology, Partnerships & Funding, Technology and platforms
  • Strong scientists: PHARMExcel’s Margaret Irwin on clinical research careers and early stage trials
    Categories: Clinical Trials, Healthcare leadership, Women in Pharma
  • Fujifilm Biotechnologies unveils ShunzymeX purification technology for biologics
    Categories: Biomanufacturing, CDMOs & Manufacturing, Events and Conferences, Pharmaceuticals and therapeutics, Research & Development, Technology and platforms
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top